{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:13:32Z","timestamp":1767665612647},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T00:00:00Z","timestamp":1120003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1038\/sj.npp.1300803","type":"journal-article","created":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T15:20:22Z","timestamp":1120058422000},"page":"2103-2114","source":"Crossref","is-referenced-by-count":57,"title":["Aripiprazole Attenuates the Discriminative-Stimulus and Subject-Rated Effects of D-Amphetamine in Humans"],"prefix":"10.1038","volume":"30","author":[{"given":"Joshua A","family":"Lile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William W","family":"Stoops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea R","family":"Vansickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E A","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lon R","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig R","family":"Rush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,6,29]]},"reference":[{"key":"BF1300803_CR1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/0006-3223(87)90070-9","volume":"22","author":"B Angrist","year":"1987","unstructured":"Angrist B, Corwin J, Bartlik B, Cooper T (1987). Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects. Biol Psychiatry 22: 1357\u20131368.","journal-title":"Biol Psychiatry"},{"key":"BF1300803_CR2","first-page":"500","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"RJ Baldessarini","year":"2001","unstructured":"Baldessarini RJ, Tarazi FI (2001). Drugs and the treatment of psychiatric disorders. In: Hardman JG, Limbird LE, Gilman AG (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill: New York. p 500."},{"key":"BF1300803_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1124\/jpet.102.033175","volume":"302","author":"KD Burris","year":"2002","unstructured":"Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T et al (2002). Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302: 381\u2013389.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300803_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/BF02244073","volume":"103","author":"PM Callahan","year":"1991","unstructured":"Callahan PM, Appel JB, Cunningham KA (1991). Dopamine D1 and D2 mediation of the discriminative stimulus properties of D-amphetamine and cocaine. Psychopharmacology 103: 50\u201355.","journal-title":"Psychopharmacology"},{"key":"BF1300803_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0028-3908(97)00010-5","volume":"36","author":"PM Callahan","year":"1997","unstructured":"Callahan PM, Cunningham KA (1997). Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists. Neuropharmacology 36: 373\u2013381.","journal-title":"Neuropharmacology"},{"key":"BF1300803_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00432219","volume":"86","author":"LD Chait","year":"1985","unstructured":"Chait LD, Uhlenhuth EH, Johanson CE (1985). The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology 86: 307\u2013312.","journal-title":"Psychopharmacology"},{"key":"BF1300803_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0165-6147(99)01422-4","volume":"21","author":"AR Childress","year":"2000","unstructured":"Childress AR, O'Brien CP (2000). Dopamine receptor partial agonists could address the duality of cocaine craving. Trends Pharmacol Sci 21: 6\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1300803_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/BF00432175","volume":"75","author":"H de Wit","year":"1981","unstructured":"de Wit H, Stewart J (1981). Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75: 134\u2013143.","journal-title":"Psychopharmacology"},{"key":"BF1300803_CR9","volume-title":"National Institute on Drug Abuse Research Monograph Series, Problems of Drug Dependence, 1997: Proceedings of the 59th Annual Scientific Meeting","author":"ME Di Marino","year":"1998","unstructured":"Di Marino ME, Haberny KA, Felch LJ, Walsh SL, Preston KL, Bigelow GE (1998). Development of a subjective rating scale sensitive to acute cocaine administration. National Institute on Drug Abuse Research Monograph Series, Problems of Drug Dependence, 1997: Proceedings of the 59th Annual Scientific Meeting, vol. 178, Scottsdale, AZ, p 139."},{"key":"BF1300803_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00008877-199212000-00008","volume":"3","author":"M Exner","year":"1992","unstructured":"Exner M, Clark D (1992). Agonist and antagonist activity of low efficacy D2 dopamine receptor agonists in rats discriminating d-amphetamine from saline. Behav Pharmacol 3: 609\u2013619.","journal-title":"Behav Pharmacol"},{"key":"BF1300803_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0091-3057(97)00559-5","volume":"60","author":"PJ Fletcher","year":"1998","unstructured":"Fletcher PJ (1998). A comparison of the effects of risperidone, racloride, and ritanserin on intravenous self-administration of d-amphetamine. Pharmacol Biochem Behav 60: 55\u201360.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300803_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF02245114","volume":"108","author":"LH Gold","year":"1992","unstructured":"Gold LH, Balster RL (1992). Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys. Psychopharmacology 108: 289\u2013294.","journal-title":"Psychopharmacology"},{"key":"BF1300803_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1517\/14656566.5.4.713","volume":"5","author":"G Gonzalez","year":"2004","unstructured":"Gonzalez G, Oliveto A, Kosten TR (2004). Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother 5: 713\u2013725.","journal-title":"Expert Opin Pharmacother"},{"key":"BF1300803_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00004714-200006000-00003","volume":"20","author":"J Grabowski","year":"2000","unstructured":"Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D et al (2000). Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmacol 20: 305\u2013310.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300803_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/sj.npp.1300392","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A et al (2004). Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29: 969\u2013981.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300803_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00213-002-1225-9","volume":"164","author":"CL Hart","year":"2002","unstructured":"Hart CL, Haney M, Foltin RW, Fischman MW (2002). Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology 164: 376\u2013384.","journal-title":"Psychopharmacology"},{"key":"BF1300803_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/BF02244241","volume":"103","author":"SJ Heishman","year":"1991","unstructured":"Heishman SJ, Henningfield JE (1991). Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans. Psychopharmacology 103: 436\u2013442.","journal-title":"Psychopharmacology"},{"key":"BF1300803_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0091-3057(01)00472-5","volume":"68","author":"E Izzo","year":"2001","unstructured":"Izzo E, Orsini C, Koob G, Pulvirenti L (2001). A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive-ratio schedule. Pharmacol Biochem Behav 68: 701\u2013708.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300803_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0091-3057(82)90343-4","volume":"17","author":"TU Jarbe","year":"1982","unstructured":"Jarbe TU (1982). Discriminative stimulus properties of d-amphetamine in pigeons. Pharmacol Biochem Behav 17: 671\u2013675.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300803_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-3-642-66612-4_4","volume-title":"Drug Addiction I","author":"D Jasinski","year":"1977","unstructured":"Jasinski D (1977). Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In: Morton WR (ed). Drug Addiction I. Springer-Verlag: New York. pp 197\u2013258."},{"key":"BF1300803_CR21","first-page":"213","volume":"241","author":"JB Kamien","year":"1989","unstructured":"Kamien JB, Woolverton WL (1989). A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J Pharmacol Exp Ther 241: 213\u2013217.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300803_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0091-3057(99)00084-2","volume":"64","author":"SH Kollins","year":"1999","unstructured":"Kollins SH, Rush CR (1999). Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans. Pharmacol Biochem Behav 64: 319\u2013326.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300803_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.drugalcdep.2004.04.010","volume":"76","author":"JA Lile","year":"2004","unstructured":"Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR (2004). Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug Alcohol Depend 76: 81\u201391.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300803_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00213-002-1183-2","volume":"164","author":"WJ Lynch","year":"2002","unstructured":"Lynch WJ, Roth ME, Carroll ME (2002). Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 164: 121\u2013137.","journal-title":"Psychopharmacology"},{"key":"BF1300803_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12: 245\u2013258.","journal-title":"Clin Pharmacol Ther"},{"key":"BF1300803_CR26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2165\/00023210-200216110-00008","volume":"16","author":"JK McGavin","year":"2002","unstructured":"McGavin JK, Goa KL (2002). Aripiprazole. CNS Drugs 16: 779\u2013786.","journal-title":"CNS Drugs"},{"key":"BF1300803_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3758\/BF03203313","volume":"14","author":"DR McLeod","year":"1982","unstructured":"McLeod DR, Griffiths RR, Bigelow GE, Yingling JE (1982). An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instr 14: 463\u2013466.","journal-title":"Behav Res Methods Instr"},{"key":"BF1300803_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00008877-199410000-00004","volume":"5","author":"MA Nader","year":"1994","unstructured":"Nader MA, Woolverton WL (1994). Blockade of the discriminative stimulus effects of d-amphetamine in rhesus monkeys with serotonin 5-HT1A agonists. Behav Pharmacol 5: 591\u2013598.","journal-title":"Behav Pharmacol"},{"key":"BF1300803_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-2999(85)90753-8","volume":"111","author":"EB Nielsen","year":"1985","unstructured":"Nielsen EB, Jepsen SA (1985). Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs. Eur J Pharmacol 111: 167\u2013176.","journal-title":"Eur J Pharmacol"},{"key":"BF1300803_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0014-2999(89)90498-6","volume":"160","author":"EB Nielsen","year":"1989","unstructured":"Nielsen EB, Randrup K, Andersen PH (1989). Amphetamine discrimination: effects of dopamine receptor agonists. Eur J Pharmacol 160: 253\u2013262.","journal-title":"Eur J Pharmacol"},{"key":"BF1300803_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/0091-3057(88)90110-4","volume":"30","author":"GG Nomikos","year":"1988","unstructured":"Nomikos GG, Spyraki C (1988). Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats. Pharmacol Biochem Behav 30: 853\u2013858.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300803_CR32","first-page":"885","volume":"261","author":"AH Oliveto","year":"1992","unstructured":"Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW (1992). Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther 261: 885\u2013894.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300803_CR33","first-page":"124","volume":"8","author":"AH Oliveto","year":"1997","unstructured":"Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Badger G (1997). Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans. Behav Pharmacol 8: 124\u2013138.","journal-title":"Behav Pharmacol"},{"key":"BF1300803_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0893-133X(01)00270-6","volume":"25","author":"C Orsini","year":"2001","unstructured":"Orsini C, Koob GF, Pulvirenti L (2001). Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 25: 789\u2013792.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300803_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s002130050875","volume":"142","author":"KA Perkins","year":"1999","unstructured":"Perkins KA, Sanders M, Fonte C, Wilson AS, White W, Stiller R et al (1999). Effects of central and peripheral nicotinic blockade on human nicotine discrimination. Psychopharmacology 142: 158\u2013164.","journal-title":"Psychopharmacology"},{"key":"BF1300803_CR36","first-page":"1232","volume":"286","author":"L Pulvirenti","year":"1998","unstructured":"Pulvirenti L, Balducci C, Piercy M, Koob GF (1998). Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. J Pharmacol Exp Ther 286: 1232\u20131238.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300803_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1037\/1064-1297.6.1.32","volume":"6","author":"CR Rush","year":"1998","unstructured":"Rush CR, Kollins SH, Pazzaglia PJ (1998). Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 6: 32\u201344.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1300803_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/01.jcp.0000130553.55630.ad","volume":"24","author":"CR Rush","year":"2004","unstructured":"Rush CR, Stoops WW, Hays LR, Glaser PEA (2004). Alprazolam attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Clin Psychopharmacol 24: 410\u2013420.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300803_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1124\/jpet.102.048439","volume":"306","author":"CR Rush","year":"2003","unstructured":"Rush CR, Stoops WW, Hays LR, Glaser PEA, Hays LS (2003). Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306: 195\u2013204.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300803_CR40","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","volume":"28","author":"DA Shapiro","year":"2003","unstructured":"Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR et al (2003). Ariprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28: 1400\u20131411.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300803_CR41","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) (2003). Results from the 2002 National Survey on Drug Use and Health: National findings. Office of Applied Studies Publications and Data Dissemination: Rockville, MD."},{"key":"BF1300803_CR42","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) (2004). Drug and Alcohol Services Information System (DASIS) report. Primary Methamphetamine\/Amphetamine Treatment Admissions Increase: 1992\u20132002. Office of Applied Studies Publications and Data Dissemination: Rockville, MD."},{"key":"BF1300803_CR43","unstructured":"United Nations Office on Drugs and Crime (2003). Ecstasy and Amphetamines Global Survey 2003. United Nations: New York, NY."},{"key":"BF1300803_CR44","first-page":"409","volume":"291","author":"ND Volkow","year":"1999","unstructured":"Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C et al (1999). Reinforcing effects of stimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors. J Pharmacol Exp Ther 291: 409\u2013415.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300803_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0006-8993(92)91327-B","volume":"593","author":"F Weiss","year":"1992","unstructured":"Weiss F, Markou A, Lorang MT, Koob GF (1992). Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593: 314\u2013318.","journal-title":"Brain Res"},{"key":"BF1300803_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2190\/QBHY-ADHA-MYMW-HCMR","volume":"34","author":"GS Yacoubian","year":"2004","unstructured":"Yacoubian GS, Peters RJ (2004). Exploring the prevalence and correlates of methamphetamine use: findings from Sacramento's ADAM program. J Drug Educ 34: 281\u2013294.","journal-title":"J Drug Educ"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300803.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300803","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300803.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:49:15Z","timestamp":1684219755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,29]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["BF1300803"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300803","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,29]]}}}